echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Another province plans to start "4 + 7" price linkage

    Another province plans to start "4 + 7" price linkage

    • Last Update: 2019-06-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Start to find out the statistics of 4 + 7 countries with the volume of drug procurement in another province! According to the feedback of mrclub netizens, Inner Mongolia Medical Insurance Bureau recently released a document (sketch) In order to deepen the reform of medical and health system and improve the mechanism of drug price formation, it is planned to select some cities as pilot cities to carry out price linkage work with volume and settlement for the selected drugs in the centralized purchase of "4 + 7" city drugs organized by the state From the perspective of content, it is expected that four cities in Inner Mongolia will take the pilot to implement the "4 + 7" price linkage, because it is volume procurement, so in order to ensure the accuracy of consumption, it is necessary to count the actual procurement volume of each hospital in 2018 and the planned procurement volume in 2019 From the information disclosed so far this year, it is imperative to follow up the first batch of 4 + 7 selected drugs in stages nationwide! "4 + 7" will expand the scope, Ma Xiaowei, director of the National Health Commission, told China Securities News in an interview at the Great Hall of the people on March 12 that "4 + 7" volume procurement will further expand the scope and promote it to the whole country, and this work will continue On November 14 last year, the fifth meeting of the Central Committee for comprehensive deepening reform deliberated and adopted the pilot program of centralized drug procurement of national organizations, which clarified the overall thinking of national organization, alliance procurement and platform operation Since then, the joint procurement office composed of representatives from 11 pilot areas has issued the "4 + 7 urban drug centralized procurement document" According to the procurement documents, 11 cities (i.e 4 + 7 cities) including Beijing, Tianjin, Shanghai, Chongqing and Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu and Xi'an will carry out the pilot drug centralized procurement organized by the state In the pilot area, representatives are appointed to form a joint procurement office as the working agency, which represents the public medical institutions in the pilot area to implement centralized procurement On March 20, Shenyang, Dalian, Shanghai and other cities uniformly implemented the results of 4 + 7 national centralized procurement On April 16, Chen Jinfu, deputy director of the state health insurance bureau, said at the regular policy briefing of the State Council that on April 1, the pilot implementation work in 11 cities was launched As of 24:00 on April 14, 27.31% of the total agreed procurement had been completed.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.